Pig liver keeps patient alive in World-First bridge trial
NCT ID NCT07519005
First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This early-phase trial tests whether a gene-edited pig liver, used outside the body like a dialysis machine, can temporarily support liver function in a single person with severe liver failure. The goal is to keep the patient stable until a human liver transplant becomes available. Participants receive strong anti-rejection drugs during the up-to-14-day treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University
Xi'an, Shaanxi, 710032, China
Conditions
Explore the condition pages connected to this study.